| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197783 Comprises nucleotide sequences coding modulator for treatment and prevention of tumor disorders; antisense/antitumor agents; immunotherapy |
| 10/07/2004 | US20040197770 Induction of apoptosis by HIV-1 infected monocytic cells |
| 10/07/2004 | US20040197766 Using transgenic animal models to identify modulator for treatment of obesity, cachexia, diabetes, insulin resistance and eating disorders |
| 10/07/2004 | US20040197431 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 10/07/2004 | US20040197426 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197415 Stable pharmaceutical compositions of dalbavancin and methods of administration |
| 10/07/2004 | US20040197391 Stable topical drug delivery compositions |
| 10/07/2004 | US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell |
| 10/07/2004 | US20040197373 Composition for filling bone defects |
| 10/07/2004 | US20040197370 Modified factor VII |
| 10/07/2004 | US20040197369 Mixing active drug with macromer; polymerization |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197336 Antitumor, anticarcinogenic agents |
| 10/07/2004 | US20040197330 Binding to lecithin receptor; viricides |
| 10/07/2004 | US20040197329 Remedies or preventives for rheumatoid arthritis |
| 10/07/2004 | US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents |
| 10/07/2004 | US20040197323 Bioavailability; amidated in situ; adjustment of pH; protective barrier for stomach |
| 10/07/2004 | US20040197321 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients |
| 10/07/2004 | US20040197320 Herbal supplement for increased muscle strength and endurance for athletes |
| 10/07/2004 | US20040197319 Wound healing composition derived from low platelet concentration plasma |
| 10/07/2004 | US20040197316 Novel method for the treatment of systemic lupus erythematosus |
| 10/07/2004 | US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response |
| 10/07/2004 | US20040197312 Anticancer agents; synergistic mixture of vaccine and antibodies , interferon or drug |
| 10/07/2004 | US20040197311 Device for regeneration of articular cartilage and other tissue |
| 10/07/2004 | US20040197307 Mixture of human interferons |
| 10/07/2004 | US20040197306 Polypeptides; used in diagnosis of gastrointestinal disorders; psoriasis;inflammatory bowel disorders; respiratory system disorders; antiallergens; atherosclerosis |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | US20040195710 Generating biocompatible microspheres; obtain macromolecule solution, mix biocompatible particles, form geometric shapes, expose shape to radiation, recover microspheres |
| 10/07/2004 | DE10313819A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 10/07/2004 | CA2816489A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | CA2731275A1 Tumour-associated peptides binding to mhc-molecules |
| 10/07/2004 | CA2520711A1 Diagnosis of advanced cancer |
| 10/07/2004 | CA2520662A1 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | CA2520497A1 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | CA2520390A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 10/07/2004 | CA2520273A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | CA2520257A1 Long acting biologically active conjugates |
| 10/07/2004 | CA2520001A1 Cyclic amp response element activator proteins and uses related thereto |
| 10/07/2004 | CA2519922A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | CA2519921A1 Asthma preparation |
| 10/07/2004 | CA2519920A1 Use of chemokine receptor agonists for stem cell transplantation |
| 10/07/2004 | CA2519826A1 Cell death-inducing fusion gene specifically acting on cancer and product thereof |
| 10/07/2004 | CA2519821A1 Treatment of infection due to clostridium difficile |
| 10/07/2004 | CA2519681A1 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 10/07/2004 | CA2519630A1 Gene expression in breast cancer |
| 10/07/2004 | CA2519465A1 Elevation of adenosine level by cytokine-induced expression of cd73 |
| 10/07/2004 | CA2519234A1 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/07/2004 | CA2519227A1 Nogo receptor binding protein |
| 10/07/2004 | CA2519114A1 Methods and compositions for treating and preventing inflammatory conditions |
| 10/07/2004 | CA2518854A1 Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor |
| 10/07/2004 | CA2518793A1 Methods of inducing immunotolerance and compositions for use therein |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | CA2517831A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia |
| 10/07/2004 | CA2517673A1 Improved vaccines for preventing viral infection |
| 10/07/2004 | CA2516414A1 Secreted protein family |
| 10/06/2004 | EP1464709A1 Detection of HPV-induced invasive cancers and their precursor lesions with invasive potential |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464697A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| 10/06/2004 | EP1464653A1 Human secreted proteinteins |
| 10/06/2004 | EP1464651A1 Dystrophin-related protein (Drop1), a marker for carcinomas |
| 10/06/2004 | EP1464339A1 Cell migration inhibitor |
| 10/06/2004 | EP1463948A2 Uses of an endothelial cell receptor |
| 10/06/2004 | EP1463842A1 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN KINASE C ALPHA (PKC-ALPHA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/06/2004 | EP1463836A2 Vector mediated organelle transfection |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463814A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 10/06/2004 | EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 10/06/2004 | EP1463811A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 10/06/2004 | EP1463806A2 Novel cyclooxygenase variants and methods of use |
| 10/06/2004 | EP1463801A2 Transdifferentiation of pancreatic acinar cells |
| 10/06/2004 | EP1463758A2 Mammal prolactin variants |
| 10/06/2004 | EP1463757A2 Antisense compounds directed against human csf-1 |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463755A2 Recombinant polypeptides |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463746A2 Antisense modulation of mucin 1, transmembrane expression |
| 10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
| 10/06/2004 | EP1463541A2 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 10/06/2004 | EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/06/2004 | EP1463524A2 METHODS OF THERAPY FOR NON−HODGKIN S LYMPHOMA |
| 10/06/2004 | EP1463523A2 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap |
| 10/06/2004 | EP1463516A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 10/06/2004 | EP1463512A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 10/06/2004 | EP1463511A1 Combination cancer therapy |
| 10/06/2004 | EP1463504A1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome |
| 10/06/2004 | EP1463493A1 Methods of inducing ovulation-using a non-polypeptide camp level modulator |
| 10/06/2004 | EP1463438A2 Endomural therapy |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1463405A2 Hair removal and animal husbandry method |
| 10/06/2004 | EP1390518B1 Buffer solution for electroporation and a method comprising the use of the same |
| 10/06/2004 | EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |